The emergence of the Internet has brought about a series of challenges and opportunities around the promotion of pharmaceuticals and the provision of health information.
Patients and those seeking health information need guidance on where to look, how to interpret what they find, and what to do with it.
The pharmaceutical industry must learn how to harness the emerging opportunities offered by the Internet whilst ensuring both product and corporate brand integrity is maintained and optimised.
Advertising Medicines And Providing Healthcare Information On The Internet, a new report from Reuters Business Insight, aims to be a single source of in-depth analysis of the relevant issues, evidence and commentary of what must be considered when formulating online strategies.
Advertising Medicines And Providing Healthcare Information On The Internet provides you with:
• Interpretation of the confused regulatory framework relating to the advertising of medicines online.

• Insight into the most effective way to ensure brand integrity is maintained.

• Case studies providing a review of strategies to illustrate best (and possibly worst) practices.

• Interviews with key executives within pharma companies, healthcare websites, licence authorities, quality assurance systems and more.

• Definitions of what represents value for money for advertisers.Benefit from over 150 pages of expert insight and analysis, enabling you to:
• Understand the regulatory framework relating to the advertising of medicines online in key markets
• Pinpoint best practice from in depth online advertising case studies
• Leverage consumer values and expectations when formulating ethical drug promotion strategies
• Predict future potential for online advertising of medicines
• Assess the role and effectiveness of online assurance schemes such as privacy policies